Philips Pays Masimo $300M To End Blood Sensor Patent Row
Masimo Corp. and Philips Electronics North America Corp. agreed to a $300 million settlement and licensing deal to close out long-running litigation over blood-oxygen measuring technology, two years after a jury...To view the full article, register now.
Already a subscriber? Click here to view full article